Since 2022, the hospital has not been providing the life-saving, clot-dissolving TPA drug and instead sending stroke patients to PGI, losing precious time ...

CLEAR III tested the benefits of the clot-busting drug alteplase, also known as tPA, in improving outcomes for intraventricular hemorrhage. In this particularly severe form of stroke, blood pools and ...

FRESNO, Calif. (KFSN) -- Stroke is the third leading cause of death in the U.S. claiming the lives of more than 140,000 Americans each year. But many lives could be spared if treatment was given ...

A new report details the case of a patient on the new experimental Alzheimer's drug, lecanemab, who died after experiencing numerous acute intracerebral hemorrhages during treatment with tissue ...

Stroke victims treated with TPA were twice as likely to have a good outcome as those who were not. The Food and Drug Administration approved it for stroke the next year, and a move grew to treat ...

Adding either argatroban or eptifibatide to thrombolytic therapy doesn't improve function following an ischemic stroke, results of new research show. "Ultimately, we found no benefit for either ...

For people with ischemic stroke, treatment with the clot-busting drug tenecteplase is associated with a slightly higher likelihood of an excellent recovery and reduced disability three months later ...

An off-label clot-busting drug appears to work slightly better in treating stroke patients than an approved medication, a new review finds. The clot-buster tenecteplase is associated with a slightly ...

Using a "neuroprotectant" drug alongside the standard surgical removal of a clot may slash the risk of death and disability following a stroke, a new study finds. The new medication, called ApTOLL, ...

CINCINNATI, Ohio. (Ivanhoe Newswire) - Stroke, it’s the leading cause of death for Americans. Every 40 seconds someone will suffer from one. There are two types…ischemic and hemorrhagic. In an ...

A recently approved drug for acute ischemic stroke works as well as the treatment used in most U.S. hospitals and may offer advantages for some patients, according to a study led by a researcher from ...